Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL04
- Pharmacological subgroupL04A
- Chemical substanceL04AL02Rozanolixizumab
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 4 registrations
United States
FDA · 4 registrations
Brazil
Anvisa · 1 registration
At a glance
- ATC code
- L04AL02
- Registers
- 7
- Registrations
- 13
- With their own page
- 13
- Companies
- 5
All medicines with Rozanolixizumab
Human medicines from every register that match Rozanolixizumab by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
13 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Rystiggo | United States | 280MG/2ML | injectable | Marketed | Ucb INC |
| Rystiggo | United States | 840MG/6ML | Injection | Marketed | UCB, Inc. |
| Rystiggo | United States | 560MG/4ML | Injection | Marketed | UCB, Inc. |
| Rystiggo | United States | 420MG/3ML | Injection | Marketed | UCB, Inc. |
| Rystiggo | European Union | Authorised | UCB Pharma | ||
| Rystiggo 140 MG/ML Solucion Inyectable | Spain | 280 mg | solución inyectable | Marketed | Ucb Pharma |
| Rystiggo 140 mg/ml oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | UCB Pharma S.A. | |
| Rystiggo | Canada | 280 MG / 2 ML | Solution | Marketed | Ucb Canada INC |
| Rystiggo | Canada | 840 MG / 6 ML | Solution | Authorised | Ucb Canada INC |
| Rystiggo | Canada | 420 MG / 3 ML | Solution | Authorised | Ucb Canada INC |
| Rystiggo | Canada | 560 MG / 4 ML | Solution | Authorised | Ucb Canada INC |
| Rystiggo | Brazil | Authorised | Ucb Biopharma Ltda. | ||
| Rystiggo | Croatia | Authorised |